Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy. - Test2 - elhamkhani - TriplyDB

Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy.

Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy.

http://www.wikidata.org/entity/Q44988169

about

Lifestyle-Related Factors in the Self-Management of Chemotherapy-Induced Peripheral Neuropathy in Colorectal Cancer: A Systematic Review.Statistical approaches for evaluating body composition markers in clinical cancer research.Improving the quality of survivorship for older adults with cancer Psoas muscle volume as a predictor of peripheral neurotoxicity induced by primary chemotherapy in ovarian cancers.The effect of geriatric intervention in frail elderly patients receiving chemotherapy for colorectal cancer: a randomized trial (GERICO).Prognostic Value of Computed Tomography: Measured Parameters of Body Composition in Primary Operable Gastrointestinal Cancers Fish oil-enriched nutrition combined with systemic chemotherapy for gastrointestinal cancer patients with cancer cachexia.Prognostic impact of sarcopenia in patients with diffuse large B-cell lymphoma treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.Cancer and Chemotherapy Contribute to Muscle Loss by Activating Common Signaling Pathways Chemotherapy-related cachexia is associated with mitochondrial depletion and the activation of ERK1/2 and p38 MAPKs.Sarcopenia and chemotherapy-mediated toxicity Systematic review of sarcopenia in patients operated on for gastrointestinal and hepatopancreatobiliary malignancies.Sarcopenia and inflammation are independent predictors of survival in male patients newly diagnosed with small cell lung cancer.Protein anabolic resistance in cancer: does it really exist?A review of body composition and pharmacokinetics in oncology.Muscle mass and association to quality of life in non-small cell lung cancer patients.The Prevalence and Prognostic Value of Low Muscle Mass in Cancer Patients: A Review of the Literature.Sarcopenia is Associated with Chemotherapy Toxicity in Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis from Colorectal Cancer.Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer: Results From the C SCANS Study.Sarcopenia is an independent predictor of complications after colorectal cancer surgery.Postoperative Changes in Body Composition After Pancreaticoduodenectomy Using Multifrequency Bioelectrical Impedance Analysis.Psoas muscle area is not representative of total skeletal muscle area in the assessment of sarcopenia in ovarian cancer.Explaining the Obesity Paradox: The Association between Body Composition and Colorectal Cancer Survival (C-SCANS Study).Muscle mass at the time of diagnosis of nonmetastatic colon cancer and early discontinuation of chemotherapy, delays, and dose reductions on adjuvant FOLFOX: The C-SCANS study.Lifestyle after Colorectal Cancer Diagnosis in Relation to Survival and Recurrence: A Review of the Literature.Negative Impact of Skeletal Muscle Wasting After Neoadjuvant Chemotherapy Followed by Surgery on Survival for Patients with Thoracic Esophageal Cancer.Sarcopenia is a novel poor prognostic factor in male patients with pathological Stage I non-small cell lung cancer.Sarcopenic overweight is associated with early acute limiting toxicity of anti-PD1 checkpoint inhibitors in melanoma patients.Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy.Oxaliplatin induces muscle loss and muscle-specific molecular changes in MICE.Nutritional support for cancer patients: still a neglected right?Linking Cancer Cachexia-Induced Anabolic Resistance to Skeletal Muscle Oxidative Metabolism.Systemic IL-6 regulation of eccentric contraction-induced muscle protein synthesis Effects of whole-body electromyostimulation combined with individualized nutritional support on body composition in patients with advanced cancer: a controlled pilot trial

P2860

Q30234847-78E9A94A-17EA-4BC9-932E-C71EB6FD5C6A Q30235361-AB3BB373-1F39-4828-AAA3-EF03528E6218 Q30250334-6671EF74-DD0E-4322-A8BD-C00047AD8520 Q33443825-7791EFF0-BB46-4284-A518-5A0CF1ECCCF3 Q33851067-CDC45CF6-EA4F-452A-A248-6575D5F758F1 Q33854959-6C50F320-3CAA-4761-9D33-782DE45E7539 Q33880985-B60F0EE7-B055-4D36-A8B1-F978C8B94068 Q36804101-6C21B374-FBCF-4994-9756-5573720850C0 Q37350003-B985B813-67EE-4ACB-9BAD-F42EC5EC336B Q37536603-C06060C6-7F4C-4CA9-859F-AA297CF77BEF Q37572738-70116141-F20C-4831-9DFB-6D42581DB8B9 Q38587843-50B45273-C8C1-408C-B737-773C3FB2DEC1 Q38627484-EA71C104-D349-4D3F-B418-E53187CCAE64 Q38631288-9FE02B6C-9518-4ADB-A7A5-B7405FC8CDB0 Q38709340-BF40E9BA-C3D1-4D58-9B6E-587FD42BAE93 Q38792305-36D34321-B311-4B4C-BFA8-1A7EF1AD4FC8 Q38842194-0E40E6DE-4DE7-4E23-B196-0C3BE6EAA911 Q39648893-4165993E-B90C-4364-9150-4D30730C4F8A Q40087436-9B3DCD10-3066-48BA-889C-15B938B15860 Q40138785-9B661F50-1BF5-43D4-965D-3FDC84E89839 Q40184674-57DC5096-9D94-4DCC-A73A-54AF5263044F Q41485323-C2B13722-2CF8-44EC-8154-34A2B0D848FD Q44662904-B829B1EB-1971-40FA-B230-B994033F9C86 Q44751659-D8545982-E509-4954-AE42-3B5CA3F420C1 Q45305281-6C246CF9-84E3-45D6-B0ED-9F6CCEBFF67C Q47159659-3842E855-D436-49AD-997A-5582AA690D7B Q47579713-92AF8FF2-07DB-4421-A98F-6F32223280A9 Q47797910-4DF5AA82-E4C4-46E9-92B7-A9B02E07FC95 Q47801764-772568A0-613B-4173-AAD3-F28280FF5A7C Q47841514-07EFBEED-CBCD-478A-A8F2-0002E8ECED30 Q48121516-79A57D7A-A57D-4378-98B8-ECEAFC109169 Q48155681-6DCB52A4-E897-44C5-9A6D-2B1FE10D5CDF Q57590461-CAEE35F3-87AC-4174-BE9B-6095DD4022F4 Q58748170-AC6CE235-EB31-4C81-B0DC-9820B983A6DA

P2860

Effect of muscle mass on toxicity and survival in patients with colon cancer undergoing adjuvant chemotherapy.

http://www.wikidata.org/entity/Q44988169

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

Effect of muscle mass on toxic ...... ergoing adjuvant chemotherapy.

@en

Effect of muscle mass on toxic ...... ergoing adjuvant chemotherapy.

@nl

type

label

Effect of muscle mass on toxic ...... ergoing adjuvant chemotherapy.

@en

Effect of muscle mass on toxic ...... ergoing adjuvant chemotherapy.

@nl

prefLabel

Effect of muscle mass on toxic ...... ergoing adjuvant chemotherapy.

@en

Effect of muscle mass on toxic ...... ergoing adjuvant chemotherapy.

@nl

P1433

Q44988169-6E192E30-202A-43A1-BF0D-79F9A834FF87

P1476

Q44988169-1A58ABDA-1835-4864-A252-BE7DA3A2E7DA

P2093

Q44988169-01D8BEAA-EEE8-41DE-9ED2-B095C6DC7DF2

Q44988169-249E6064-47EE-4BB1-9F2D-041D312C7DA1

Q44988169-356BF684-BD90-4A18-AF49-AFF5E4CB4CE8

Q44988169-364D650A-E180-494C-B2C6-68A7B2AAF73E

Q44988169-50588E46-A40C-4BA6-A662-6E02BA30F86F

Q44988169-6A3EEFEA-7D9A-4D49-96E5-08A11DC66866

Q44988169-770107A6-5F51-4FC7-930C-98446AC156CE

Q44988169-8758417F-E3FD-4380-AFDD-1EDB25850222

Q44988169-9DE6D32A-7BE4-45E1-BC35-B4A22A007839

Q44988169-A8C20EED-4AB1-4FB8-9ED6-8AEBFB3E3CDA

P2860

Q44988169-0006114B-74CD-4BA5-9A76-C01355B9BE65

Q44988169-06F955D1-F5E5-4391-8F13-3711B29D868F

Q44988169-1EFC9FFE-8557-4462-BE1F-20C2EB829538

Q44988169-29C5C6AC-630D-4117-A006-637150A28322

Q44988169-31E6C80E-FBC2-43C8-891A-8DC21026281B

Q44988169-35019B01-7EAB-4C76-B487-0401FBF321B5

Q44988169-384769DE-ED1B-4259-AC50-B6F952D89C53

Q44988169-388F97D2-59F0-4094-A8EA-38A741588676

Q44988169-4248289E-6977-440D-93C1-666DCB43ABB6

Q44988169-43628736-1B54-4564-9A3C-3C1824EB7051

P2888

Q44988169-2C26185B-3519-43E7-9C9F-6D1B4ECD6ECB

P304

Q44988169-BBF9BD50-8AAC-4494-82B3-82EFC7ACB0E8

P31

Q44988169-628F7A52-95D0-4AD2-8930-3AE1748AB2E2

P356

Q44988169-EF2678DE-05C5-44FB-AE4C-06D160630B6C

P433

Q44988169-F3A5AAE3-F261-4D52-B93D-A6C0A6FCB5A7

P478

Q44988169-818851C6-E193-4D19-B267-621F5672E81D

P50

Q44988169-57139341-2B65-4848-A7A7-FCD4DAE861C9

P577

Q44988169-248FB680-16C7-4379-B391-1CAF2C49A634

P5875

Q44988169-5867EA7E-7FCF-4E0F-B62F-CC95C92DB120

P698

Q44988169-BDD9A857-9146-414B-810B-C8F208DAD978

P921

Q44988169-25CD0F7C-B955-4967-8170-5BEDB24E65D4

Q44988169-906EBB15-1EBA-4ECF-862D-72634FE42B5F

P356

S00520-014-2418-6

P1433

Supportive Care in Cancer

P1476

Effect of muscle mass on toxic ...... ergoing adjuvant chemotherapy.

@en

P2093

Cheol-Ho Kim

http://www.w3.org/2001/XMLSchema#string

Duck-Woo Kim

http://www.w3.org/2001/XMLSchema#string

Hyun Kyung Yang

http://www.w3.org/2001/XMLSchema#string

Jee Hyun Kim

http://www.w3.org/2001/XMLSchema#string

Ji-Yeon Kim

http://www.w3.org/2001/XMLSchema#string

Jin Won Kim

http://www.w3.org/2001/XMLSchema#string

Joon Woo Lee

http://www.w3.org/2001/XMLSchema#string

Keun-Wook Lee

http://www.w3.org/2001/XMLSchema#string

Kwang-Il Kim

http://www.w3.org/2001/XMLSchema#string

Sun-Wook Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer

Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People

Frailty in older adults: evidence for a phenotype

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

Toxicity and response criteria of the Eastern Cooperative Oncology Group

The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates.

Frailty in elderly people

Sarcopenia and mortality after liver transplantation.

Global patterns of cancer incidence and mortality rates and trends.

Obesity is an independent prognostic variable in colon cancer survivors.

P2888

s00520-014-2418-6

P304

687-694

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00520-014-2418-6

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-08-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265134759

http://www.w3.org/2001/XMLSchema#string

P698

25163434

http://www.w3.org/2001/XMLSchema#string

P921